Prognostic value of pretreatment serum carcinoembryonic antigen and squamous cell carcinoma antigen levels for patients with stage I–III non-small cell lung cancer treated with radiation therapy alone

[1]  T. Ohno,et al.  The role of radiation therapy for stage IIIB non-small cell lung cancer: Impact of clinical nodal stage on survival , 1996, International Journal of Clinical Oncology.

[2]  T. Terao,et al.  Clinical evaluation of squamous cell carcinoma antigen in squamous cell carcinoma arising in mature cystic teratoma of the ovary. , 1995, Oncology.

[3]  R. Molina,et al.  Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC. , 1995, Anticancer Research.

[4]  J. Balibrea,et al.  Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer , 1995, The International journal of biological markers.

[5]  F. Masa,et al.  Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer. , 1994, Chest.

[6]  N. Mitsuhashi,et al.  Effect of krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer. , 1993, Anticancer research.

[7]  N. Mitsuhashi,et al.  Radiation therapy for Stage I-III epidermoid carcinoma of the lung , 1992 .

[8]  N. Mitsuhashi,et al.  [The clinical usefulness of serum SCC antigen level determinations in patients with malignant tumor]. , 1987, Nihon Gan Chiryo Gakkai shi.

[9]  H. Fritsche,et al.  Use of carcinoembryonic antigen in small cell lung cancer prognostic value and relation to the clinical course 1 , 1987, Cancer.

[10]  K. Eguchi,et al.  Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy , 1986, Cancer.

[11]  N. Mitsuhashi,et al.  [The clinical evaluation of serum CA 19-9 and CA 125 levels in patients with malignant tumors. Comparison with serum CEA levels]. , 1985, Kaku igaku. The Japanese journal of nuclear medicine.

[12]  G. Hortobagyi,et al.  Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer. , 1983, JAMA.

[13]  K. Isselbacher,et al.  Carcinoembryonic antigen: its role as a marker in the management of cancer. A National Institutes of Health Consensus Development Conference. , 1981, Annals of internal medicine.

[14]  Carcinoembryonic antigen: its role as a marker in the management of cancer. Summary of an NIH consensus statement. , 1981, British medical journal.

[15]  G. Liebler,et al.  Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma , 1978, Cancer.

[16]  C. Dunnett,et al.  Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma , 1978, Cancer.

[17]  J. Hayward,et al.  Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer. , 1975, European journal of cancer.

[18]  R. Taylor,et al.  CARCINOEMBRYONIC ANTIGEN , 1974 .

[19]  K. Isselbacher,et al.  CEA (carcinoembryonic antigen): Its role as a marker in the management of cancer , 2004, Journal of Cancer Research and Clinical Oncology.

[20]  N. Mitsuhashi,et al.  Histological Types and Radiation Effects , 1983 .

[21]  T. M. Chu,et al.  CEA monitoring of palliative treatment for colorectal carcinoma. , 1977, Annals of surgery.